June 8, 2025
Intangible Assets

Actym Therapeutics Announces Issuance of US Patents

Actym Therapeutics has strengthened its IP portfolio with two newly issued patents covering its novel STACT™ biological platform technology and therapeutic agents utilizing the platform. BERKELEY, Calif., June 02, 2025–(BUSINESS WIRE)–Actym Therapeutics, a clinical-stage therapeutic product development and platform company, today announced the issuance of US patent Nos. 12,201,653 and 12,226,439 by the United States

Read More
Intangible Assets

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

NeOnc Technologies Holdings, Inc. — 176 Patents Issued and Outstanding Reinforces NeOnc’s Competitive Position — CALABASAS, Calif., April 15, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a biopharmaceutical company focused on the development of novel oncology and neurology therapeutics, today announced that its global patent portfolio totals 176, reinforcing its competitive position.

Read More